TOKYO--(BUSINESS WIRE)--Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer ...

The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...

Urethral strictures refer to the narrowing of the urethra, which is the tube that carries urine out of the body. This condition is typically caused by scarring, which can block or narrow the urethra, ...

TOKYO--(BUSINESS WIRE)--A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six ...

The FDA has granted approval to Urotronic Inc. for its Optilume urethral drug-coated balloon (DCB) for the treatment of male urethral strictures. The device inhibits new scar tissue growth that may ...

STRICTURES of the human urethra are of three types: inflammatory, traumatic and congenital. The basic histology 1 common to all strictures is a proliferation of fibroblasts in the tunica propria. This ...

Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients ...

Aug. 7, 2002 -- Routine direct vision internal urethrotomy (DVIU) is better than treating only on recurrence for urethral strictures, according to the results of a prospective, randomized trial ...

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. Investigators in South Korea demonstrated the benefit in a ...

The FDA has granted approval to Urotronic Inc. for its Optilume urethral drug-coated balloon (DCB) for the treatment of male urethral strictures. The device inhibits new scar tissue growth that may ...